Kymera Therapeutics, Inc.

8-K Director or officer change; Regulation FD disclosure Jul 27, 2026 8-K Regulation FD disclosure; Other events Jun 25, 2026 8-K Shareholder vote results Jun 24, 2026 8-K Director or officer change Jun 8, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 8-K Amended charter or bylaws Mar 27, 2026 8-K Entered a material agreement; Terminated a material agreement; Other events Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 8-K Entered a material agreement; Other events Dec 10, 2025 8-K Regulation FD disclosure Dec 8, 2025 8-K Regulation FD disclosure; Other events Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Director or officer change; Regulation FD disclosure Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Entered a material agreement; Other events Jun 27, 2025 8-K Shareholder vote results Jun 27, 2025 8-K Regulation FD disclosure; Other events Jun 25, 2025 8-K Regulation FD disclosure; Other events Jun 25, 2025 8-K Regulation FD disclosure Jun 2, 2025 8-K Regulation FD disclosure; Other events Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2025 8-K Director or officer change Mar 3, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Director or officer change Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 14, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 8-K Entered a material agreement; Other events Aug 20, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Regulation FD disclosure; Other events Jul 8, 2024 8-K Director or officer change; Shareholder vote results Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024